SITC 2022 – Using Additional Morphology Markers in NanoString® GeoMx® Whole Transcriptome Atlas Assay to Assess NSCLC Tumor Subtypes By Andrew Borgmann Posted November 18, 2022 In Poster/Presentation SITC 2022 – Using Additional Morphology Markers in NanoString® GeoMx® Whole Transcriptome Atlas Assay to Assess NSCLC Tumor Subtypes2022-11-182022-11-18/wp-content/uploads/2022/02/canopy-logo-2022-white.pngCanopy Biosciences/wp-content/uploads/2022/02/canopy-logo-2022-white.png200px200px 0 NanoString GeoMx Andrew Borgmann Recent PostsNew life science startup raises $2 million
